![Colin Goddard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 427 840 $ al 30/06/2026
Colin Goddard is Non-Executive Chairman at MISSION Therapeutics Ltd. since 2017, Executive Chairman at FoRx Therapeutics AG, Director at Azelon Pharmaceuticals, Inc., Director at Gilda's Club, Director at PanOptica, Inc. since 2011, Director at Merganser Biotech, Inc., Director at HiberCell, Inc. since 2019, Member at the American Association for Cancer Research, and Member-Supervisory Board at Ryvu Therapeutics SA. Former roles include President & Chief Executive Officer at OSI Pharmaceuticals, Inc. from 1998 to 2010, Chairman & Chief Executive Officer at BlinkBio, Inc. from 2012 to 2022, Executive Chairman at OS Therapies, Inc. from 2020 to 2024, Independent Director at Human Genome Sciences, Inc. from 2011 to 2012, Independent Director at Endocyte, Inc. from 2013 to 2018, and Director at Biotechnology Innovation Organization, Agendia NV, Abilities, Inc., Pharmaceutical Research & Manufacturers of America, Long Island Association, Inc., Agendia, Inc., Drug Discovery & Development Solutions Ltd., and Trustee at Hofstra University.
Education includes undergraduate studies at The University of York and a doctorate from the University of Aston conferred in 1985.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2024 | 225.179 ( 0,51 % ) | 427 840 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Director/Miembro de la Junta | - |
FoRx Therapeutics AG
 FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops cancer treatment compounds | Presidente | - |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs for the treatment of osteoporosis | Director/Miembro de la Junta | - |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Director/Miembro de la Junta | 06/08/2019 |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Presidente | 01/01/2017 |
Merganser Biotech, Inc.
 Merganser Biotech, Inc. BiotechnologyHealth Technology Provides biotechnology services | Director/Miembro de la Junta | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | - |
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs for treatment of eye diseases | Director/Miembro de la Junta | 05/04/2011 |
Gilda's Club | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░ ░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 26 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Azelon Pharmaceuticals, Inc.
Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs for the treatment of osteoporosis | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
BlinkBio, Inc.
 BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules | Health Technology |
Hofstra University
 Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Abilities, Inc. | |
The University of York
 The University of York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Long Island Association, Inc.
 Long Island Association, Inc. Miscellaneous Commercial ServicesCommercial Services Seeks ways to develop businesses and communities in the Long Island region | Commercial Services |
Gilda's Club | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology Manufactures ophthalmology drugs for treatment of eye diseases | Health Technology |
Ryvu Therapeutics SA
 Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
Merganser Biotech, Inc.
Merganser Biotech, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Drug Discovery & Development Solutions Ltd.
 Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in drug discovery and development | Commercial Services |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Commercial Services |
OS Therapies, Inc.
 OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
FoRx Therapeutics AG
FoRx Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops cancer treatment compounds | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
